Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Sell
1,428
-44
-3% -$15.1K 0.04% 200
2026
Q1
$518K Buy
1,472
+92
+7% +$32.8K 0.05% 197
2025
Q4
$452K Buy
1,380
+54
+4% +$17.1K 0.04% 204
2025
Q3
$374K Sell
1,326
-149
-10% -$43.2K 0.04% 211
2025
Q2
$412K Sell
1,475
-149
-9% -$42.2K 0.04% 200
2025
Q1
$506K Buy
1,624
+59
+4% +$17.4K 0.06% 163
2024
Q4
$408K Buy
1,565
+199
+15% +$59K 0.05% 169
2024
Q3
$440K Sell
1,366
-8,864
-87% -$2.9M 0.05% 155
2024
Q2
$3.2M Sell
10,230
-163
-2% -$47.9K 0.44% 50
2024
Q1
$2.95M Buy
10,393
+153
+1% +$44.8K 0.42% 54
2023
Q4
$2.95M Sell
10,240
-1,060
-9% -$289K 0.47% 47
2023
Q3
$3.01M Buy
11,300
+82
+0.7% +$20.5K 0.53% 41
2023
Q2
$2.49M Buy
11,218
+274
+3% +$63.6K 0.43% 53
2023
Q1
$2.65M Buy
+10,944
New +$2.69M 0.48% 50
2022
Q4
Sell
-8,301
Closed -$1.87M 42
2022
Q3
$1.87M Buy
8,301
+698
+9% +$169K 0.43% 52
2022
Q2
$1.85M Sell
7,603
-2,195
-22% -$538K 0.38% 54
2022
Q1
$2.37M Sell
9,798
-2,773
-22% -$637K 0.45% 48
2021
Q4
$2.83M Buy
12,571
+588
+5% +$124K 0.46% 46
2021
Q3
$2.55M Buy
11,983
+1,826
+18% +$420K 0.51% 46
2021
Q2
$2.48M Buy
10,157
+7,252
+250% +$1.78M 0.5% 49
2021
Q1
$723K Buy
+2,905
New +$693K 0.16% 88

Other funds holding AMGN

Allen Capital Group's AMGN Position: Q2 2026 in Review

Allen Capital Group reduced its Amgen (AMGN) stake by 3% in Q2 2026, selling an estimated $15.1K and leaving 1,428 shares worth $517K. The position accounts for 0.04% of the portfolio, ranked #200.

Allen Capital Group first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.2M in Q2 2024. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Allen Capital Group held 1,428 shares of Amgen worth $517K as of Q2 2026.
  • Allen Capital Group sold 44 Amgen shares in Q2 2026, an estimated $15.1K.
  • Amgen made up 0.04% of Allen Capital Group's portfolio in Q2 2026, its #200 holding.
  • Allen Capital Group first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
  • Allen Capital Group's Amgen position peaked at $3.2M in Q2 2024.
  • 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.